Axenov-Gribanov Denis V, Morgunova Maria M, Vasilieva Ulyana A, Gamaiunov Stanislav V, Dmitrieva Krasnova Maria E, Pereliaeva Ekaterina V, Belyshenko Alexander Yu, Luzhetskyy Andriy N
Irkutsk State University, 1 Karl Marx St, 664003 Irkutsk, Russia.
Siberian Institute of Plant Physiology and Biochemistry, 132 Lermontov Str, 664033 Irkutsk, Russia.
3 Biotech. 2021 Aug;11(8):386. doi: 10.1007/s13205-021-02926-1. Epub 2021 Jul 28.
Growth of human population leads to many global and medical problems. The problems include the crisis of health, antibiotic resistance, drug discovery, etc. Increasing antimicrobial resistance of microorganisms results in the need to screen natural products (incl. antibiotics and antimicrobial peptides) and their producers in different ecological niches. The purpose of this study was to estimate antibiotic activity and biotechnological potential of rare actinobacteria sp. The strain was isolated from Okhotnichya cave located in Siberia. Here, we cultivated the strain at 3 temperature modes (13 °C, 28 °C, 37 °C) in 11 liquid nutrient (rich and poor) media. Using modern assays of liquid chromatography and high-resolution mass spectrometry, we estimated the content and number of produced natural products, distribution of their masses, and potential rate of novel secondary metabolites. We demonstrated that minimal nutrient media with l-asparagine and SM25 media with malt extract were less productive at current experimental parameters. As it was shown, this strain was characterized by antibiotic properties against when cultivated at 28 °C. Also, weak antibiotic activity of crude extracts was found in strain cultivation at 13 °C. Also, we detected a high number of novel amphiphilic and hydrophobic NPs produced by this strain. We demonstrated both the influence of the nutrient media composition and cultivation temperature on biosynthetic capabilities of rare strain sp. Finally, high level of natural products that were predicted as novel confirms high biotechnological value of rare genera of Actinobacteria that could be explained by the evolution of microorganisms in the isolated environment of cave ecosystem.
人口增长导致了许多全球性和医学问题。这些问题包括健康危机、抗生素耐药性、药物发现等。微生物抗菌耐药性的增加导致需要在不同生态位中筛选天然产物(包括抗生素和抗菌肽)及其生产者。本研究的目的是评估稀有放线菌菌株的抗生素活性和生物技术潜力。该菌株是从位于西伯利亚的奥赫特尼奇亚洞穴中分离出来的。在这里,我们在11种液体营养(丰富和贫乏)培养基中,于3种温度模式(13℃、28℃、37℃)下培养该菌株。使用现代液相色谱和高分辨率质谱分析方法,我们估计了所产生天然产物的含量和数量、它们的质量分布以及新型次生代谢产物的潜在生成率。我们证明,在当前实验参数下,含有L-天冬酰胺的基本营养培养基和含有麦芽提取物的SM25培养基的产量较低。结果表明,该菌株在28℃培养时具有抗生素特性。此外,在13℃培养该菌株时,粗提物的抗生素活性较弱。我们还检测到该菌株产生了大量新型两亲性和疏水性天然产物。我们证明了营养培养基组成和培养温度对稀有菌株的生物合成能力均有影响。最后,预测为新型的天然产物的高水平证实了稀有放线菌属的高生物技术价值,这可以通过洞穴生态系统隔离环境中微生物的进化来解释。